Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01341171 · ClinicalTrials.gov registry record
The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins
A clinical trial, sponsored by University of Vermont.
- Completed
- Registry status
- 30
- Enrollment target
NCT01341171 is a clinical trial that has completed, run by University of Vermont. The registered enrollment target is 30 participants.
The verdict
NCT01341171 has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Single phlebotomy study involving women receiving tamoxifen or aromatase inhibitor therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-08 |
| Est. Completion | 2018-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01341171
The ClinicalTrials.gov registry entry for NCT01341171 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01341171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01341171 about?
NCT01341171 is a clinical study titled "The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins". Single phlebotomy study involving women receiving tamoxifen or aromatase inhibitor therapy.
What is the current status of trial NCT01341171?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2009-08. Estimated completion is 2018-10.
Who is sponsoring clinical trial NCT01341171?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.